Latest filing published 08 Jun 2026 for 10x Genomics, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Sridhar Kosaraju, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Nevro Corp and 10x Genomics, Inc. We count 34 filings; the first trade dates from 24 May 2021 and the latest from 4 June 2026.
Every open-market trade on record is a sale: 8 sales worth €650k. Other entries cover 23 share grants and 2 option exercises.
The record was last updated on 8 June 2026 with a share grant in 10x Genomics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 34 declarations